Surgical Science Sweden Management
Management criteria checks 4/4
Surgical Science Sweden's CEO is Gisli Hennermark, appointed in Sep 2015, has a tenure of 8.67 years. total yearly compensation is SEK5.83M, comprised of 73.7% salary and 26.3% bonuses, including company stock and options. directly owns 0.67% of the company’s shares, worth SEK53.76M. The average tenure of the management team and the board of directors is 3.3 years and 5.2 years respectively.
Key information
Gisli Hennermark
Chief executive officer
kr5.8m
Total compensation
| CEO salary percentage | 73.7% |
| CEO tenure | 8.7yrs |
| CEO ownership | 0.7% |
| Management average tenure | 3.3yrs |
| Board average tenure | 5.2yrs |
Recent management updates
Recent updates
Earnings Beat: Surgical Science Sweden AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 21
Here's Why Surgical Science Sweden (STO:SUS) Has Caught The Eye Of Investors
Apr 16Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Is Still Matching Investor Opinion Despite 25% Slump
Mar 17Results: Surgical Science Sweden AB (publ) Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 24Is There Now An Opportunity In Surgical Science Sweden AB (publ) (STO:SUS)?
Nov 29Should You Be Adding Surgical Science Sweden (STO:SUS) To Your Watchlist Today?
Oct 07Is Surgical Science Sweden AB (publ) (STO:SUS) Trading At A 39% Discount?
Aug 17With EPS Growth And More, Surgical Science Sweden (STO:SUS) Makes An Interesting Case
Jun 20A Look At The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
May 17Surgical Science Sweden AB (publ) (STO:SUS) Shares Could Be 49% Below Their Intrinsic Value Estimate
Dec 27Is Now The Time To Put Surgical Science Sweden (STO:SUS) On Your Watchlist?
Dec 06Is Now The Time To Look At Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Sep 08We Ran A Stock Scan For Earnings Growth And Surgical Science Sweden (STO:SUS) Passed With Ease
Aug 23Surgical Science Sweden AB (publ) (STO:SUS) Shares Slammed 33% But Getting In Cheap Might Be Difficult Regardless
May 26Here's Why We Think Surgical Science Sweden (STO:SUS) Is Well Worth Watching
Apr 29An Intrinsic Calculation For Surgical Science Sweden AB (publ) (STO:SUS) Suggests It's 44% Undervalued
Feb 20Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jan 11Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Dec 15Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Sep 16Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Jul 05Calculating The Fair Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Jun 08Is It Too Late To Consider Buying Surgical Science Sweden AB (publ) (STO:SUS)?
Mar 23Calculating The Intrinsic Value Of Surgical Science Sweden AB (publ) (STO:SUS)
Mar 02Is Surgical Science Sweden AB (publ)'s (STO:SUS) Shareholder Ownership Skewed Towards Insiders?
Feb 09
Surgical Science Sweden AB (publ)'s (STO:SUS) Stock Is Going Strong: Have Financials A Role To Play?
Jan 01What Does Surgical Science Sweden AB (publ)'s (STO:SUS) Share Price Indicate?
Dec 14Does Surgical Science Sweden (STO:SUS) Deserve A Spot On Your Watchlist?
Nov 26CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | kr6m | kr4m | kr234m |
| Sep 30 2023 | n/a | n/a | kr253m |
| Jun 30 2023 | n/a | n/a | kr234m |
| Mar 31 2023 | n/a | n/a | kr221m |
| Dec 31 2022 | kr5m | kr4m | kr188m |
| Sep 30 2022 | n/a | n/a | kr138m |
| Jun 30 2022 | n/a | n/a | kr124m |
| Mar 31 2022 | n/a | n/a | kr101m |
| Dec 31 2021 | kr4m | kr3m | kr86m |
Compensation vs Market: Gisli's total compensation ($USD529.70K) is below average for companies of similar size in the Swedish market ($USD789.50K).
Compensation vs Earnings: Gisli's compensation has been consistent with company performance over the past year.
CEO
Gisli Hennermark (51 yo)
8.7yrs
Tenure
kr5,826,000
Compensation
Mr. Gisli Hennermark serves as Chief Executive Officer of Surgical Science Sweden AB (publ) since September 2015. He serves as board member of Panasari AB and Espansari AB. He worked previously as a manage...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 8.7yrs | kr5.83m | 0.67% SEK 53.8m | |
| Co-Founder & CTO | 5.3yrs | no data | 0.093% SEK 7.5m | |
| Chief Financial Officer | 6.3yrs | no data | 0.047% SEK 3.8m | |
| Chief Operating Officer | 3.3yrs | no data | 0.036% SEK 2.9m | |
| Head of Global Sales | 3.3yrs | no data | no data | |
| Executive Vice President of Products & Marketing | 2.5yrs | no data | 0.036% SEK 2.9m | |
| Head of Development | 4.5yrs | no data | no data | |
| Chief Innovation Officer | 3.3yrs | no data | no data | |
| President of Research & Development | 2.3yrs | no data | 0.042% SEK 3.4m | |
| Executive Vice President of International Sales & Educational Products | no data | no data | 0.010% SEK 808.8k | |
| Executive Vice President of Industry & OEM | 2yrs | no data | no data |
3.3yrs
Average Tenure
54yo
Average Age
Experienced Management: SUS's management team is considered experienced (3.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | 19.3yrs | no data | 11.74% SEK 941.4m | |
| Director | 19.3yrs | no data | 13.99% SEK 1.1b | |
| Independent Director | 7.3yrs | no data | 0.0020% SEK 157.1k | |
| Independent Director | less than a year | no data | no data | |
| Independent Director | 3yrs | no data | 0.0026% SEK 204.4k | |
| Independent Director | 3yrs | no data | 0.0020% SEK 157.1k |
5.2yrs
Average Tenure
53.5yo
Average Age
Experienced Board: SUS's board of directors are considered experienced (5.2 years average tenure).